M Dezfulian

1.1k total citations
28 papers, 709 citations indexed

About

M Dezfulian is a scholar working on Neurology, Molecular Biology and Immunology. According to data from OpenAlex, M Dezfulian has authored 28 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 9 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in M Dezfulian's work include Botulinum Toxin and Related Neurological Disorders (12 papers), Diphtheria, Corynebacterium, and Tetanus (4 papers) and Immunotherapy and Immune Responses (4 papers). M Dezfulian is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (12 papers), Diphtheria, Corynebacterium, and Tetanus (4 papers) and Immunotherapy and Immune Responses (4 papers). M Dezfulian collaborates with scholars based in United States, Iran and Canada. M Dezfulian's co-authors include John G. Bartlett, V. R. Dowell, C L Hatheway, Stephen J. Elledge, Charlotte I. Wang, Tomasz Kula, Zachary C. Hartman, H. Kim Lyerly, Nouran S. Abdelfattah and Kai W. Wucherpfennig and has published in prestigious journals such as Cell, Nature Biotechnology and PLoS ONE.

In The Last Decade

M Dezfulian

26 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Dezfulian United States 13 239 222 209 147 73 28 709
Frank Detmers Netherlands 13 499 2.1× 136 0.6× 67 0.3× 83 0.6× 36 0.5× 22 830
Jacqueline M. Tremblay United States 21 522 2.2× 142 0.6× 301 1.4× 46 0.3× 17 0.2× 41 1.1k
Marek Szatanik France 15 195 0.8× 83 0.4× 106 0.5× 24 0.2× 17 0.2× 18 636
Susanne Herbst United Kingdom 12 294 1.2× 173 0.8× 356 1.7× 56 0.4× 33 0.5× 20 1.0k
Takahiro Kamimoto Japan 10 661 2.8× 30 0.1× 222 1.1× 52 0.4× 39 0.5× 12 1.5k
Yasir Mohamud Canada 18 366 1.5× 63 0.3× 192 0.9× 102 0.7× 21 0.3× 37 762
Chiara Rodighiero United States 7 468 2.0× 31 0.1× 245 1.2× 25 0.2× 35 0.5× 9 880
G A Myers United States 7 466 1.9× 57 0.3× 105 0.5× 47 0.3× 22 0.3× 9 999
Jean‐Christophe Marvaud France 22 328 1.4× 394 1.8× 310 1.5× 20 0.1× 15 0.2× 35 1.1k
Zhijie Lin China 19 387 1.6× 29 0.1× 172 0.8× 60 0.4× 103 1.4× 49 886

Countries citing papers authored by M Dezfulian

Since Specialization
Citations

This map shows the geographic impact of M Dezfulian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Dezfulian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Dezfulian more than expected).

Fields of papers citing papers by M Dezfulian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Dezfulian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Dezfulian. The network helps show where M Dezfulian may publish in the future.

Co-authorship network of co-authors of M Dezfulian

This figure shows the co-authorship network connecting the top 25 collaborators of M Dezfulian. A scholar is included among the top collaborators of M Dezfulian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Dezfulian. M Dezfulian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohlgruber, Ayano C., M Dezfulian, Brandon Sie, et al.. (2024). High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits. Nature Biotechnology. 43(4). 623–634. 16 indexed citations
2.
Meng, Qingda, Shanshan Xie, G. Kenneth Gray, et al.. (2021). Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids. Journal for ImmunoTherapy of Cancer. 9(11). e003213–e003213. 54 indexed citations
3.
Kula, Tomasz, M Dezfulian, Charlotte I. Wang, et al.. (2019). T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes. Cell. 178(4). 1016–1028.e13. 155 indexed citations
5.
Dezfulian, M, et al.. (2016). Oligomerization of SCFTIR1 Is Essential for Aux/IAA Degradation and Auxin Signaling in Arabidopsis. PLoS Genetics. 12(9). e1006301–e1006301. 36 indexed citations
6.
Khalili, Saeed, Mohammad Reza Rahbar, M Dezfulian, & Abolfazl Jahangiri. (2015). In silico analyses of Wilms׳ tumor protein to designing a novel multi-epitope DNA vaccine against cancer. Journal of Theoretical Biology. 379. 66–78. 31 indexed citations
8.
Sardari, Soroush & M Dezfulian. (2007). Cheminformatics in Anti-Infective Agents Discovery. Mini-Reviews in Medicinal Chemistry. 7(2). 181–189. 7 indexed citations
9.
Sardari, Soroush & M Dezfulian. (2007). Evaluation of SAR for Amphotericin B Derivatives by Artificial Neural Network. Tropical Journal of Pharmaceutical Research. 4(2). 2 indexed citations
10.
Dezfulian, M. (1999). Aerobic growth and toxigenicity ofClostridium botulinum types A and B. Folia Microbiologica. 44(2). 167–170. 5 indexed citations
11.
Rodríguez, Angela & M Dezfulian. (1997). Rapid identification ofClostridium botulinum and botulinal toxin in food. Folia Microbiologica. 42(2). 149–151. 12 indexed citations
12.
Dezfulian, M, et al.. (1994). Physiological characteristics ofClostridium bifermentans selectively isolated from California desert tortoise. Folia Microbiologica. 39(6). 496–500. 8 indexed citations
13.
Dezfulian, M. (1993). A simple procedure for identification ofClostridium botulinum colonies. World Journal of Microbiology and Biotechnology. 9(1). 125–127. 1 indexed citations
14.
Dezfulian, M, et al.. (1987). Kinetics study of immunological response to Clostridium botulinum toxin. Journal of Clinical Microbiology. 25(7). 1336–1337. 7 indexed citations
15.
Dezfulian, M & John G. Bartlett. (1985). Kinetics of growth and toxigenicity of Clostridium botulinum in experimental wound botulism. Infection and Immunity. 49(2). 452–454. 9 indexed citations
16.
Bartlett, John G., et al.. (1982). Efficacy of Moxalactam in an Animal Model of Subcutaneous Abscesses: Penetration into Infected Sites and in Vivo Activity Against Bacteroides fragilis. Clinical Infectious Diseases. 4(Supplement_3). S664–S669. 3 indexed citations
17.
Dezfulian, M, L M McCroskey, C L Hatheway, & V. R. Dowell. (1981). Selective medium for isolation of Clostridium botulinum from human feces. Journal of Clinical Microbiology. 13(3). 526–531. 74 indexed citations
18.
Dezfulian, M & V. R. Dowell. (1980). Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases. Journal of Clinical Microbiology. 11(6). 604–609. 36 indexed citations
19.
Mathé, G, et al.. (1973). Applicable in cancer immunotherapy.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1987. 6 indexed citations
20.
Lavrin, David H., M Dezfulian, & David Weiss. (1965). The antigen responsible for acquired resistance to spontaneous mammary carcinomas in mice. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026